Literature DB >> 2028643

Cost considerations of conversion from aminoglycoside-containing combination regimens to ceftriaxone.

L L Briceland, W R Outman, C H Nightingale, R Quintiliani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2028643     DOI: 10.1177/106002809102500324

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


× No keyword cloud information.
  3 in total

1.  Evaluating IV drug delivery systems.

Authors:  J Garrelts
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

Review 2.  Methods of minimising the cost of aminoglycoside therapy to hospitals.

Authors:  C A Gentry; K A Rodvold; J S Bertino
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

Review 3.  Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.

Authors:  A Adu; C L Armour
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.